[
  {
    "ts": "2026-02-17T08:00:00+00:00",
    "headline": "Resurrect Bio announces $8.1M initial close of Series A led by Corteva",
    "summary": "Resurrect Bio, a biotechnology company revolutionizing agriculture by equipping crops with genetic defenses against disease, today announced the successful initial closing of its Series A funding round at $8.1M. The investment was led by Corteva through its Corteva Catalyst platform, with participation from Calculus Capital, Pymwymic, UKI2S, SynBioVen, and AgFunder.",
    "url": "https://finance.yahoo.com/news/resurrect-bio-announces-8-1m-080000270.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "8e4dfb5d-d98e-3bd2-a245-cd0b0aec4a7a",
      "content": {
        "id": "8e4dfb5d-d98e-3bd2-a245-cd0b0aec4a7a",
        "contentType": "STORY",
        "title": "Resurrect Bio announces $8.1M initial close of Series A led by Corteva",
        "description": "",
        "summary": "Resurrect Bio, a biotechnology company revolutionizing agriculture by equipping crops with genetic defenses against disease, today announced the successful initial closing of its Series A funding round at $8.1M. The investment was led by Corteva through its Corteva Catalyst platform, with participation from Calculus Capital, Pymwymic, UKI2S, SynBioVen, and AgFunder.",
        "pubDate": "2026-02-17T08:00:00Z",
        "displayTime": "2026-02-17T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/3c7c4b3b226210f956c2abd4068b3cc6",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y7HU6p0.JVcUiR8K.eUfow--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/3c7c4b3b226210f956c2abd4068b3cc6.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TrcH4a3Scbwzap3k4N4Tgg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/3c7c4b3b226210f956c2abd4068b3cc6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/resurrect-bio-announces-8-1m-080000270.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/resurrect-bio-announces-8-1m-080000270.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CTVA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]